Business Wire

VMware by IKOULA: An Introductory Offer to Familiarize Yourself With The VMware Environment, While Controlling Your Budget

Share

Nowadays virtualization and hyperconvergence are among the concerns of many companies, IKOULA – a key player in the European IaaS market – aims to democratize the use of VMware technology by offering a VMware introductory offer, packaged to create and operate its own virtual datacenter(s), with a low budget.

Available at €69 / month excl. VAT, this introductory offer includes 1 vCPU (2,9 Ghz), 4 GB of vRAM, 100 GB of hard disk, 1 IPv4 address and an unlimited traffic volume.

Bringing together in a single secure environment all the storage, computing and network resources necessary for any activities, the VMware Cloud Director solution puts an end to physical infrastructures in silos, and guarantees companies an optimized use of these material resources, with a maximized ROI, controlled costs as well as the interoperability and portability of their applications between their different clouds.

What are the benefits for companies using VMware?

  • Simplified provisioning and consumption: users benefit from a single access point, making it very easy to provision all kinds of cloud services, but also third-party services, such as Kubernetes containers or programming interfaces for DevOps.
  • Flexibility and responsiveness: companies will be able at any time and with just a few clicks to deploy usual or highly personalized services according to their needs.
  • Simple migration of workloads between different virtual data centers.
  • Optimized IT costs, thanks to the consolidation of resources managed through a single interface and the automation of some IT tasks.
  • 100% French hosting of all data, in accordance with the GDPR, avoiding any foreign interference.
  • Technical support available 24/7

About IKOULA

Pioneer of the French Cloud since 1998, IKOULA has its own Datacenters in France, as well as two subsidiaries, in Spain and in the Netherlands. Because people are part of its DNA, IKOULA maintains a close relationship with its customers, and provides them with teams of experts available 24/7, to advise and support them in their activities. IKOULA's teams are also multilingual, in order to respond to the internationalization issues of all of its customers, located in more than 60 countries on 4 continents.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contacts
Laurane VASSOR ARCARO – communication director
lvassorarcaro@ikoula.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release

Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing

Illumynt Reports Q3 2025 Business Update17.10.2025 15:39:00 EEST | Press release

Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia17.10.2025 15:15:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the new indication for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia. In June 2025, Avanzanite entered into an exclusive agreement with Agios to commercialize and distribute PYRUKYND across the European Economic Area, the United Kingdom, and Switzerland. “The positive CHMP opinion for PYRUKYND represents a key step toward making th

Kinaxis Accelerates Agentic Era for Supply Chain Orchestration with the Launch of Maestro Agents17.10.2025 14:00:00 EEST | Press release

Kinaxis® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced Maestro Agents, marking the next milestone in AI-enabled decision intelligence for supply chains. Now available to Kinaxis customers and embedded natively in Kinaxis Maestro®, these AI-powered context aware digital co-workers help planners move faster from issue to action, turning disruption into opportunity, and strengthening the resilience of the supply chains that power the global economy. “Kinaxis agents are already helping our planning team collaborate more effectively with customers and contract manufacturers,” said John Finnigan, Senior Director, Advanced Planning at Jabil. “With human-in-the-loop safeguards, we’re reaching decisions faster today and see strong potential to build a more resilient and networked supply chain.” Maestro Agents advance the customer journey from conversational AI to decision-based agentic supply chain orchestration. Unlike generic AI assistants that sit outside th

SLB Announces Third-Quarter 2025 Results17.10.2025 13:50:00 EEST | Press release

SLB (NYSE: SLB) today announced results for the third-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015948706/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2025Jun. 30, 2025Sept. 30, 2024SequentialYear-on-yearRevenue $8,928 $8,546 $9,159 4% -3% Income before taxes - GAAP basis $1,000 $1,285 $1,507 -22% -34% Income before taxes margin - GAAP basis 11.2% 15.0% 16.5% -383 bps -525 bps Net income attributable to SLB - GAAP basis $739 $1,014 $1,186 -27% -38% Diluted EPS - GAAP basis $0.50 $0.74 $0.83 -32% -40% Adjusted EBITDA* $2,061 $2,051 $2,343 0% -12% Adjusted EBITDA margin* 23.1% 24.0% 25.6% -92 bps -249 bps Pretax segment operating income* $1,626 $1,584 $1,902 3% -14% Pretax segment operating margin* 18.2% 18.5% 20.8% -32 bps -255 bps Net income attributable to SLB, excluding charges & credit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye